ELDERPHARM

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated January 30, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Ltd has submitted to the Exchange vide its letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings PVT Ltd has submitted to the Exchange vide letter dated January 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt Ltd has submitted to the Exchange vide its letter dated January 15, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt ltd has submitted to the Exchange vide its letter dated January 10, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports PVT. Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Niti Saxena has submitted to the Exchange vide letter dated December 12, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports PVT. Ltd has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Niti Saxena has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulations 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings PVT Ltd has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Ltd has submitted to the Exchange vide letter dated November 30, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Private Limited has submitted to the Exchange vide its letter dated June 12, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Private Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Pvt Ltd has submitted to the Exchange vide its letter dated April 27, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Private Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Private Limited has submitted to the Exchange vide its letter dated March 26, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for pledge of 25000 shares.

Indarts Exports Private Limited has submitted to the Exchange vide its letter dated March 26,2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for release of 25000 shares.

Cholamandalam Investment and Finance Company Limited has submitted to the Exchange vide its letter dated March 22, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt. Ltd. has submitted to the Exchange vide its letter dated March 20, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt. Ltd. has submitted to the Exchange vide its letter dated March 15, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exports Pvt. Ltd . has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Indarts Exoports Pvt. Ltd . has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Akshaya Holdings Pvt. Limited has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Semit Pharmaceuticals & Chemicals Pvt. Ltd. has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 5000 shares on June 16, 2006; 1,217 shares on June 20, 2006 and 3,000 shares on June 23, 2006 aggregating to 0.047% of the total paid up capital of Elder Pharmaceuticals Limited . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 1853516 shares aggregating to 10.60% of the total paid up capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 3455 shares on June 14,2006 and 12138 shares on June 15,2006 aggregating to 0.079% of the total share capital of Elder Pharmaceuticals Limited . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 1844299 shares aggregating to 10.55% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 8412 shares on June 8,2006 and 700 shares on June 9,2006 aggregating to 0.044% of the total share capital of Elder Pharmaceuticals Limited . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 1828706 shares aggregating to 10.46% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 10,624 shares aggregating to 0.04% of the total share capital of Elder Pharmaceuticals Limited on June 06, 2006 and acquired 31,481 shares aggregating to 0.18% of the total share capital of Elder Pharmaceuticals Limited on June 07, 2006. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 18,19,594 shares aggregating to 10.41% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 10,000 shares aggregating to 0.05% of the total share capital of Elder Pharmaceuticals Limited on May 22, 2006. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 17,77,489 shares aggregating to 10.17% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 17,000 shares aggregating to 0.09% of the total share capital of Elder Pharmaceuticals Limited on March 10, 2006. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 16,82,349 shares aggregating to 9.62% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Citigroup Banking Corporation A/c CBC Bahrain has acquired 125,700 shares aggregating to 0.71% of the total share capital of Elder Pharmaceuticals Limited on March 03, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Citicorp Banking Corporation A/c CBC Bahrain after the said acquisition is 915,588 shares aggregating to 5.22% of the total share capital of Elder Pharmaceuticals Limited.

Citigroup has informed the Exchange that Citigroup Banking Corporation A/c Cbc Bahrain alongwith Pac : Citigroup International Finance Corporation Limited has acquired 1,25,700 shares aggregating to 0.71% of the total paid up capital of Elder Pharmaceuticals Limited on March 03, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Citigroup Banking Corporation A/c Cbc Bahrain alongwith Pac : Citigroup International Finance Corporation Limited after the said acquisition is 9,15,588 shares aggregating to 5.22% of the total paid up capital of Elder Pharmaceut

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Private Limited has acquired shares of Elder Pharmaceuticals Limited as follows: (1) 17,000 shares (0.09%) on March 02, 2006 and (2) 17,000 shares (0.09%) on March 06, 2006. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 1665349 shares aggregating to 9.53% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Citigroup International Finance Corporation(CIFC) and CBC Bahrain (PAC) has acquired 78,905 shares of the total paid up capital of Elder Pharmaceuticals Limited on March 02, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Citigroup International Finance Corporation and CBC Bahrain (PAC) after the said acquisition is 12,80,000 shares of CIFC and 7,89,888 shares of CBC Bahrain shares aggregating to 11.81% of the total share capital of Elder Pharmaceuticals Limited.

Citibank, N.A. has informed the Exchange that CBC Bahrain and Citigroup International Finance Corporation (PAC) has acquired 78,905 shares of Elder Pharmaceuticals Limited on March 02, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of CBC Bahrain and Citigroup International Finance Corporation (PAC) after the said acquisition is 12,80,000 shares of CIFC and 7,89,888 shares of CBC Bahrain shares aggregating to 11.81% of the total share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Private Limited has acquired shares of Elder Pharmaceuticals Limited as follows: (1) 25,000 shares (0.143%) on January 24, 2006 and (2) 10,000 shares (0.057%) on January 27, 2006. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 1631349 shares aggregating to 9.33% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Private Limited has acquired 2,00,000 shares aggregating to 1.14% of the share capital of Elder Pharmaceuticals Limited on September 26, 2005. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 15,96,350 shares aggregating to 9.14% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited had informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 250,000 shares on July 01, 2005 and 250,000 shares on July 04, 2005, of the Company. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 12,96,100 shares aggregating to 7.41% of the share capital of Elder Pharmaceuticals Limited. The Company has now amended that the post holding of Indarts Exports Pvt. Ltd. after the said acquisition is 13,96,350 shares aggregating to 7.99% of the share capital of Elder Pharmaceuticals L

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired shares of the Company as follows: (i) 100,000 shares (0.57%) on May 23, 2005 through the Open Market; (ii) 200 shares on June 23, 2005 through Private arrangement; (iii) 50 shares on July 08, 2005 through Private arrangement. The shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 8,96,350 shares aggregating to 5.13% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 250,000 shares on July 01, 2005 and 250,000 shares on July 04, 2005, of the Company. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 12,96,100 shares aggregating to 7.41% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange regarding the change in shareholding of CBC Bahrain and Citicorp International Finance Corporation(PAC).The details of the same are as follows: CBC Bahrain has acquired 1,00,000 equity shares aggregating to 0.57% of the share capital of Elder Pharmaceuticals Limited on May 24, 2005.The mode of acquisition is through Secondary Market Purchases and the shareholding of Citicorp International Finance Corporation after the said acquisition is 12,80,000* shares and that of CBC Bahrain is 5,00,000 shares of Elder Pharmaceuticals Limited. *Citic

Citibank N.A. has informed the exchange regarding the change in shareholding of Citicorp International Finance Corporation(CIFC) with PAC as CBC Bahrain.The details of the same are as follows: CBC Bahrain has acquired 1,65,000 shares aggregating to 0.94% of the share capital of Elder Pharmaceuticals Limited on May 23, 2005.The mode of acquisition through Secondary Market Purchases and the shareholding of Citicorp International Finance Corporation after the said acquisition is 12,80,000 shares aggregating to 7.33% and that of CBC Bahrain is 4,00,000 shares aggregating to 2.29% of the share ca

Citibank N.A. has informed the exchange regarding the change in shareholding of CBC Bahrain and Citicorp International Finance Corporation(PAC).The details of the same are as follows: CBC Bahrain has acquired 1,00,000 equity shares aggregating to 0.57% of the total paid up capital of Elder Pharmaceuticals Limited on May 24, 2005.The mode of acquisition is through Secondary Market Purchases and the shareholding of Citicorp International Finance Corporation after the said acquisition is 12,80,000* shares and that of CBC Bahrain is 5,00,000 shares of Elder Pharmaceuticals Limited.The aggregate s

Citibank has informed the exchange that Citigroup International Finance Corporation along with PAC CBC Bahrain has acquired 12,80,000 equity shares aggregating to 7.30%* of the total paid up capital of Elder Pharmaceuticals Limited on May 19,2005.The mode of acquisition is preferential allotment and the shareholding of Citigroup International Finance corporation along with PAC CBC Bahrain after the said acquisition is 12,80,000 shares aggregating to 7.30%* of the total paid up capital of the company. *Citigroup International Finance Corporation has also been allotted 4,50,000 warrants which i

Elder Pharmaceuticals Limited has informed the Exchange that Citigroup International Finance Corporation has acquired 12,80,000 shares aggregating to 7.30%* of the share capital of Elder Pharmaceuticals Limited on May 19, 2005. The mode of acquisition is through Preferential Allotment and the shareholding of Citigroup International Finance Corporation after the said acquisition is 12,80,000 shares aggregating to 7.30%* of the share capital of Elder Pharmaceuticals Limited. [*Citigroup International Finance Corporation has also been allotted 4,50,000 warrants which is not part of the shares or

Elder Pharmaceuticals Limited has submitted to the Exchange the details of acquisition of 5% or more shares by Indarts Exports Pvt. Ltd. in Elder Pharmaceuticals Ltd on November 04,2004. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Elder Pharmaceuticals Limited has informed the Exchange that Semit Pharmaceuticals & Chemicals Pvt. Ltd have acquired 260,000 shares representing 1.63% of the voting rights of the Company. The date of acquisition is October 12, 2004 and mode of acquisition is through Private Arrangement. The shareholding of Semit Pharmaceuticals & Chemicals Pvt. Ltd after the said acquisition is 11,41,750 shares representing 7.14% of the voting rights of Elder Pharmaceuticals Limited.